Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets.

Salou M, Legoux F, Gilet J, Darbois A, du Halgouet A, Alonso R, Richer W, Goubet AG, Daviaud C, Menger L, Procopio E, Premel V, Lantz O.

J Exp Med. 2018 Dec 5. pii: jem.20181483. doi: 10.1084/jem.20181483. [Epub ahead of print]

PMID:
30518599
2.

"We Don't Really Do Anything Unless it's Really Bad": Understanding Adolescent Sun Protective Knowledge, Attitudes and Behaviors in the U.S.

Fitch-Martin AR, Menger LM, Loomis AD, Hartsough LES, Henry KL.

J Prim Prev. 2018 Jul 14. doi: 10.1007/s10935-018-0515-x. [Epub ahead of print]

PMID:
30008040
3.

A Guide to the Design of Occupational Safety and Health Training for Immigrant, Latino/a Dairy Workers.

Menger LM, Rosecrance J, Stallones L, Roman-Muniz IN.

Front Public Health. 2016 Dec 23;4:282. doi: 10.3389/fpubh.2016.00282. eCollection 2016. Review.

4.

Perceptions of Health and Safety among Immigrant Latino/a Dairy Workers in the U.S.

Menger LM, Pezzutti F, Tellechea T, Stallones L, Rosecrance J, Roman-Muniz IN.

Front Public Health. 2016 May 30;4:106. doi: 10.3389/fpubh.2016.00106. eCollection 2016.

5.

TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors.

Menger L, Sledzinska A, Bergerhoff K, Vargas FA, Smith J, Poirot L, Pule M, Hererro J, Peggs KS, Quezada SA.

Cancer Res. 2016 Apr 15;76(8):2087-93. doi: 10.1158/0008-5472.CAN-15-3352. Erratum in: Cancer Res. 2017 Jun 15;77(12 ):3379. Cancer Res. 2016 Oct 15;76(20):6130.

6.

Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.

Śledzińska A, Menger L, Bergerhoff K, Peggs KS, Quezada SA.

Mol Oncol. 2015 Dec;9(10):1936-65. doi: 10.1016/j.molonc.2015.10.008. Epub 2015 Oct 26. Review.

7.

Understanding the experiences and needs of female commercial sex workers in Kathmandu, Nepal.

Kaufman MR, Harman JJ, Menger LM, Shrestha DK.

Health Care Women Int. 2016 Aug;37(8):872-88. doi: 10.1080/07399332.2015.1118103. Epub 2015 Nov 17.

PMID:
26576656
8.

TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.

Menger L, Gouble A, Marzolini MA, Pachnio A, Bergerhoff K, Henry JY, Smith J, Pule M, Moss P, Riddell SR, Quezada SA, Peggs KS.

Blood. 2015 Dec 24;126(26):2781-9. doi: 10.1182/blood-2015-08-664755. Epub 2015 Oct 27.

9.

Consensus guidelines for the detection of immunogenic cell death.

Kepp O, Senovilla L, Vitale I, Vacchelli E, Adjemian S, Agostinis P, Apetoh L, Aranda F, Barnaba V, Bloy N, Bracci L, Breckpot K, Brough D, Buqué A, Castro MG, Cirone M, Colombo MI, Cremer I, Demaria S, Dini L, Eliopoulos AG, Faggioni A, Formenti SC, Fučíková J, Gabriele L, Gaipl US, Galon J, Garg A, Ghiringhelli F, Giese NA, Guo ZS, Hemminki A, Herrmann M, Hodge JW, Holdenrieder S, Honeychurch J, Hu HM, Huang X, Illidge TM, Kono K, Korbelik M, Krysko DV, Loi S, Lowenstein PR, Lugli E, Ma Y, Madeo F, Manfredi AA, Martins I, Mavilio D, Menger L, Merendino N, Michaud M, Mignot G, Mossman KL, Multhoff G, Oehler R, Palombo F, Panaretakis T, Pol J, Proietti E, Ricci JE, Riganti C, Rovere-Querini P, Rubartelli A, Sistigu A, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Sukkurwala AQ, Tartour E, Thorburn A, Thorne SH, Vandenabeele P, Velotti F, Workenhe ST, Yang H, Zong WX, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2014 Dec 13;3(9):e955691. eCollection 2014 Oct. Review.

10.

Unveiling the silence: women's sexual health and experiences in Nepal.

Menger LM, Kaufman MR, Harman JJ, Tsang SW, Shrestha DK.

Cult Health Sex. 2015;17(3):359-73. doi: 10.1080/13691058.2014.937462. Epub 2014 Jul 18.

PMID:
25036591
11.

'This is a natural process': managing menstrual stigma in Nepal.

Crawford M, Menger LM, Kaufman MR.

Cult Health Sex. 2014;16(4):426-39. doi: 10.1080/13691058.2014.887147. Epub 2014 Apr 4.

PMID:
24697583
12.

Crosstalk between ER stress and immunogenic cell death.

Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L.

Cytokine Growth Factor Rev. 2013 Aug;24(4):311-8. doi: 10.1016/j.cytogfr.2013.05.001. Epub 2013 Jun 17. Review.

PMID:
23787159
13.

Fluorescent biosensors for the detection of HMGB1 release.

Martins I, Kepp O, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Vacchelli E, Galluzzi L, Kroemer G.

Methods Mol Biol. 2013;1004:43-56. doi: 10.1007/978-1-62703-383-1_4.

PMID:
23733568
14.

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

Ma Y, Adjemian S, Mattarollo SR, Yamazaki T, Aymeric L, Yang H, Portela Catani JP, Hannani D, Duret H, Steegh K, Martins I, Schlemmer F, Michaud M, Kepp O, Sukkurwala AQ, Menger L, Vacchelli E, Droin N, Galluzzi L, Krzysiek R, Gordon S, Taylor PR, Van Endert P, Solary E, Smyth MJ, Zitvogel L, Kroemer G.

Immunity. 2013 Apr 18;38(4):729-41. doi: 10.1016/j.immuni.2013.03.003. Epub 2013 Apr 4.

15.

Trial watch: Cardiac glycosides and cancer therapy.

Menger L, Vacchelli E, Kepp O, Eggermont A, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2013 Feb 1;2(2):e23082.

16.

Quantification of cell cycle-arresting proteins.

Kepp O, Martins I, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Galluzzi L, Kroemer G.

Methods Mol Biol. 2013;965:121-42. doi: 10.1007/978-1-62703-239-1_7.

PMID:
23296654
17.

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects.

Kepp O, Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Sukkurwala AQ, Michaud M, Galluzzi L, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 Dec 1;1(9):1640-1642.

18.

Cardiac glycosides exert anticancer effects by inducing immunogenic cell death.

Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, Yamazaki T, Sukkurwala AQ, Michaud M, Mignot G, Schlemmer F, Sulpice E, Locher C, Gidrol X, Ghiringhelli F, Modjtahedi N, Galluzzi L, André F, Zitvogel L, Kepp O, Kroemer G.

Sci Transl Med. 2012 Jul 18;4(143):143ra99. doi: 10.1126/scitranslmed.3003807.

19.

Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer.

Vacchelli E, Galluzzi L, Rousseau V, Rigoni A, Tesniere A, Delahaye N, Schlemmer FD, Menger L, Sukkurwala AQ, Adjemian S, Martins I, Michaud M, Dunant A, Kepp O, Brambilla E, Soria JC, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 May 1;1(3):271-278.

20.

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death.

Martins I, Michaud M, Sukkurwala AQ, Adjemian S, Ma Y, Shen S, Kepp O, Menger L, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G.

Autophagy. 2012 Mar;8(3):413-5. doi: 10.4161/auto.19009. Epub 2012 Feb 24.

PMID:
22361584
21.

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice.

Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, Ghiringhelli F, di Virgilio F, Zitvogel L, Kroemer G.

Science. 2011 Dec 16;334(6062):1573-7. doi: 10.1126/science.1208347.

22.

Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.

Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G.

Cancer Metastasis Rev. 2011 Mar;30(1):61-9. doi: 10.1007/s10555-011-9273-4. Review.

PMID:
21249425
23.

[Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy].

Kroemer G, Adjemian S, Michaud M, Martins I, Kepp O, Sukkurwala AQ, Menger L, Vacchelli E, Ma Y, Zitvogel L.

Bull Mem Acad R Med Belg. 2011;166(3-4):130-8; discussion 139-40. French.

PMID:
22375493
24.

Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress.

Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N, Tesniere A, Zitvogel L, Kroemer G.

Oncogene. 2011 Mar 10;30(10):1147-58. doi: 10.1038/onc.2010.500. Epub 2010 Dec 13.

PMID:
21151176
25.

Surface-exposed calreticulin in the interaction between dying cells and phagocytes.

Martins I, Kepp O, Galluzzi L, Senovilla L, Schlemmer F, Adjemian S, Menger L, Michaud M, Zitvogel L, Kroemer G.

Ann N Y Acad Sci. 2010 Oct;1209:77-82. doi: 10.1111/j.1749-6632.2010.05740.x. Review.

PMID:
20958319
26.

Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway.

Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G.

Clin Cancer Res. 2010 Jun 15;16(12):3100-4. doi: 10.1158/1078-0432.CCR-09-2891. Epub 2010 Apr 26.

Supplemental Content

Loading ...
Support Center